Offer - Urjas Oil for just ₹ 1 X
Ifoxan + Mesna Injection is a commercial drug that is prescribed in the form of Injection. The alternative uses of Ifoxan + Mesna Injection have also been explained below.
The optimal dosage of Ifoxan + Mesna Injection is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Common side effects of Ifoxan + Mesna Injection include Lightheadedness. Besides the aforementioned side effects, there are other adverse effects of Ifoxan + Mesna Injection as well, which are listed below. Normally, these side effects of Ifoxan + Mesna Injection are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Ifoxan + Mesna Injection has a Severe effect for pregnant women and Severe effect on lactating mothers. Warnings related to Ifoxan + Mesna Injection's effects on the liver, heart and kidney, if any, have been listed below.
Ifoxan + Mesna Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Ifoxan + Mesna Injection in conditions like Herpes, Infections. Other contraindications of Ifoxan + Mesna Injection have been discussed in the sections ahead.
Drug interactions for Ifoxan + Mesna Injection have been reported in the medical literature. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Ifoxan + Mesna Injection is considered not safe while driving, and is not addictive.
Ifoxan + Mesna Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Male) |
|
Geriatric |
|
Is the use of Ifoxan + Mesna Injection safe for pregnant women?
Ifoxan + Mesna can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Ifoxan + Mesna Injection safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Ifoxan + Mesna. So it is adviced to consult the doctor before using it.
What is the effect of Ifoxan + Mesna Injection on the Kidneys?
Very few cases of side effects of Ifoxan + Mesna on kidney have been reported.
What is the effect of Ifoxan + Mesna Injection on the Liver?
Ifoxan + Mesna has very mild side effects on the liver.
What is the effect of Ifoxan + Mesna Injection on the Heart?
There are no any side effects of Ifoxan + Mesna for the heart.
Ifoxan + Mesna Injection should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Ifoxan + Mesna Injection unless your doctor advises you to do so -
Is this Ifoxan + Mesna Injection habit forming or addictive?
No, there is no any evidence that Ifoxan + Mesna Injection is addictive.
Interaction between Food and Ifoxan + Mesna Injection
Taking Ifoxan + Mesna Injection with food does not harm your health.
Interaction between Alcohol and Ifoxan + Mesna Injection
Consult your doctor before consuming alcohol while taking Ifoxan + Mesna Injection as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Mesnex (mesna)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 860, 876
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 822-824
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 670-671
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 860
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ifex (ifosfamide)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Holoxan (ifosfamide)